All In MedTech

FDA Clearance Tracker · P050038-S023

ARISTA AH, ARISTA AH FLEXITIP/ FLEXITIP XL/ FLEXITIP XL-R

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 16, 2015 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P050038-S023
Device name
ARISTA AH, ARISTA AH FLEXITIP/ FLEXITIP XL/ FLEXITIP XL-R
Applicant
Davol, Inc.
Applicant location
Warwick, RI
Received
Jul 29, 2014
Decided
Mar 16, 2015
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P050038

Device type

Device class
Class III
Regulation
21 CFR 878.4490

Every decision under product code LMG

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE LINE EXTENSION OF THE FLEXITIP XL APPLICATOR FAMILY TO INCLUDE THE FLEXITIP XL-R APPLICATOR. THE MODIFICATION IS BASED UPON THE CURRENT APPLICATOR DESIGN BUT NOW INCLUDES AN ADDITIONAL OUTER STAINLESS STEEL TUBING TO CREATE A RIGID (XL-R) PORTION OF THE APPLICATOR TIP. IN ADDITION, APPROVAL FOR REVISION OF THE INSTRUCTIONS FOR USE OF THE ARISTA AH PRODUCT LABELING IN ORDER TO INFORM USERS OF USE OF THE NEW APPLICATOR DURING ENDOSCOPIC/ LAPAROSCOPIC USES.

Source documents

Other decisions for Davol, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.